As cancer cells frequently rely on the complementary activities of BCL-xL and MCL-1 for their survival15,37,38 we propose that the paracrine effects of paclitaxel, through IFN/TNF dependent NOXA induction, enhance BCL-xL dependency by decreasing the influence of MCL-1. This evidence concerns the gene BCL2L1 and cancer.